X
Please Wait
Applying Filters...
01 DOXYCYCLINE HYCLATE (8)
01 MAYNE PHARMA (8)
01 TABLET, DELAYED RELEASE;ORAL (8)
01 EQ 100MG BASE (1)
02 EQ 120MG BASE (1)
03 EQ 150MG BASE (1)
04 EQ 200MG BASE (1)
05 EQ 50MG BASE (1)
06 EQ 60MG BASE (1)
07 EQ 75MG BASE (1)
08 EQ 80MG BASE (1)
01 USA (8)
19
Mayne Pharma, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 50795 and regulatory information .
proudly manufactured in the
approval since 2016-05-20
Mayne Pharma's DORYX MPC TABLET, DELAYED RELEASE;ORAL, medication with EQ 60MG BASE of DOXYCYCLINE HYCLATE.
18
Mayne Pharma, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 50795 and regulatory information .
proudly manufactured in the
approval since 2013-04-11
Mayne Pharma's DORYX TABLET, DELAYED RELEASE;ORAL, medication with EQ 200MG BASE of DOXYCYCLINE HYCLATE.
17
Mayne Pharma, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 50795 and regulatory information .
proudly manufactured in the
approval since 2008-06-20
Mayne Pharma's DORYX TABLET, DELAYED RELEASE;ORAL, medication with EQ 150MG BASE of DOXYCYCLINE HYCLATE.
16
Mayne Pharma, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 50795 and regulatory information .
proudly manufactured in the
approval since 2016-05-20
Mayne Pharma's DORYX MPC TABLET, DELAYED RELEASE;ORAL, medication with EQ 120MG BASE of DOXYCYCLINE HYCLATE.
15
Mayne Pharma, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 50795 and regulatory information .
proudly manufactured in the
approval since 2005-05-06
Mayne Pharma's DORYX TABLET, DELAYED RELEASE;ORAL, medication with EQ 75MG BASE of DOXYCYCLINE HYCLATE.
14
Mayne Pharma, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 50795 and regulatory information .
proudly manufactured in the
approval since 2014-12-19
Mayne Pharma's DORYX TABLET, DELAYED RELEASE;ORAL, medication with EQ 50MG BASE of DOXYCYCLINE HYCLATE.
13
Mayne Pharma, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 50795 and regulatory information .
proudly manufactured in the
approval since 2013-04-11
Mayne Pharma's DORYX TABLET, DELAYED RELEASE;ORAL, medication with EQ 80MG BASE of DOXYCYCLINE HYCLATE.
12
Mayne Pharma, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 50795 and regulatory information .
proudly manufactured in the
approval since 2005-05-06
Mayne Pharma's DORYX TABLET, DELAYED RELEASE;ORAL, medication with EQ 100MG BASE of DOXYCYCLINE HYCLATE.
Market Place
